Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

Can COVID-19 cause, uncover or otherwise activate diabetes?

As many as 14% of patients with severe COVID-19 develop type I or type II diabetes––and doctors are bewildered by the association. 

 

Thumbnail

Routine chest imaging all AI needs to spot impending heart maladies

AI has proven capable of automatically detecting looming heart trouble on CT scans taken for lung issues like lung cancer, pulmonary embolism and pneumonia.

AI recognizes cognitive decline in headshots

Researchers have used deep learning software to accurately detect age-related cognitive impairment using only photos of patients’ faces.

AI learns COVID’s language to predict its next move

The idea is to head off serious gathering threats without getting thrown off the scent by strains unlikely to proliferate.

Skin cancer AI not quite ready for clinical primetime

AI melanoma detectors that equaled or bettered dermatologists in clinical trials have stumbled on the way to the real world of patient care. 

AI-enabled EHRs could help head off severe asthma attacks

The tools could be used by primary care providers to head off adverse respiratory events and suboptimal healthcare utilization. 

FDA clears AI software for reading portable MRI brain scans

An AI application that interprets MRI scans of the brain for signs or confirmation of injury has received 510(k) clearance from the FDA.

Predicting psychiatric readmission proves ‘hard for humans, hard for machines’

Researchers have found that some AI models do better, on average, than expert psychiatrists at the difficult task.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup